SB 983 Hawaii Senate · 2018 Regular Session

RELATING TO WORKERS' COMPENSATION PRESCRIPTION DRUGS.

Summary
Requires an opioid therapy informed consent process agreement to be executed between an injured employee and a physician who prescribes opioids within the State under certain conditions. Requires the harm reduction services branch of the department of health to develop and make available a template of an opioid therapy informed consent process agreement between injured employees and physicians for use in the State and advise the department of labor and industrial relations on the contents of the agreement. Limits prescriptions for compounded prescription drugs to a 30-day supply and reimbursements for compounded prescription drugs to an unspecified amount in a thirty-day period. Limits reimbursements for any schedule II drug under chapter 329, Uniform Controlled Substances Act, Hawaii Revised Statutes, dispensed by a physician to reimbursement for an initial, seven-day supply upon the first visit. Effective 7/1/2050. (SD1)
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2017
Committee Review
Floor Vote
Governor
Introduced Jan 25, 2017 Last action Jan 17, 2018
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
10
Key actions
2
Committee
7
Jan 17, 2018
Committee
Re-Referred to CPH, LBR.
upper
Feb 16, 2017
Committee
Report adopted; Passed Second Reading, as amended (SD 1) and referred to JDL.
upper
Feb 16, 2017
Committee
Reported from CPH (Stand. Com. Rep. No. 391) with recommendation of passage on Second Reading, as amended (SD 1) and referral to JDL.
upper
Feb 9, 2017
Upper · Passed
The committee(s) on CPH recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in CPH were as follows: 4 Aye(s): Senator(s) Baker, Nishihara, S. Chang, Espero; Aye(s) with reservations: none ; 0 No(es): none; and 3 Excused: Senator(s) Ihara, Kidani, Ruderman.
upper
Feb 2, 2017
Upper · Passed
The committee(s) on CPH has scheduled a public hearing on 02-09-17 9:00AM in conference room 229.
upper
Jan 30, 2017
Committee
Re-Referred to CPH, JDL.
upper
Jan 25, 2017
Committee
Referred to PSM/CPH, JDL.
upper
Jan 25, 2017
Introduced
Introduced.
upper
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.